Venetoclax and blinatumomab based chemotherapy-free treatment in a patient with Philadelphia chromosome-negative acute lymphoblastic leukemia

Ann Hematol. 2023 May;102(5):1275-1277. doi: 10.1007/s00277-023-05127-3. Epub 2023 Mar 9.

Jie Chang^#^{1

2}, Yao-Jia Shen^#^{1

2}, Ting Shi^#^{1

2}, Hua-Feng Wang^{1

2

3}, Jie Jin^{1

2

3}, Hong-Hu Zhu^{4

5

6

7}

¹ Department of Hematology, College of Medicine, The First Affiliated Hospital, Zhejiang University, 79# Qingchun Road, Hangzhou, 310003, Zhejiang, China.
² Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, Zhejiang, China.
³ Zhejiang University Cancer Center, Hangzhou, Zhejiang, China.
⁴ Department of Hematology, College of Medicine, The First Affiliated Hospital, Zhejiang University, 79# Qingchun Road, Hangzhou, 310003, Zhejiang, China. [email protected].
⁵ Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, Zhejiang, China. [email protected].
⁶ Zhejiang University Cancer Center, Hangzhou, Zhejiang, China. [email protected].
⁷ Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, Zhejiang, China. [email protected].

^# Contributed equally.

No abstract available

Publication types